Preparing for the Clinic: How to build a smart clinical filling strategy (線上活動)

Preparing for the Clinic: How to build a smart clinical filling strategy (線上活動)

The transition from preclinical development to clinical manufacturing is a crucial pivot point in the lifecycle of any new drug product. It’s also a step where many biotech companies run into challenges – from project delays and cost overruns, to operational snags and regulatory friction.   In this webcast, we’ll explore key steps and strategies that can help biotech companies successfully navigate the critical shift from early-stage development to clinical manufacturing. Join us to learn about some of the most important best practices your product team should consider as you plan to make the leap from the bench to the clinic. 

活動介紹

60-minute webcast on how biotech companies can streamline the critical pivot from early-stage product development to clinical manufacturing.  

The transition from preclinical development to clinical manufacturing is a crucial pivot point in the lifecycle of any new drug product. It’s also a step where many biotech companies run into challenges – from project delays and cost overruns, to operational snags and regulatory friction.  

In this webcast, we’ll explore key steps and strategies that can help biotech companies successfully navigate the critical shift from early-stage development to clinical manufacturing. Join us to learn about some of the most important best practices your product team should consider as you plan to make the leap from the bench to the clinic. 

Sign up for our free 60-min webcast to learn: 

  • How to build and activate an efficient, de-risked clinical manufacturing strategy for your compound 

  • How the right strategy can help accelerate development of your product while protecting its quality 

  • How having a strategic CDMO partner can help put you and your product on the path to success in the clinic 

活動議程

Date: Thursday, March 18, 2021

Time: 12:00 PM 

Duration: 1 hour


Speakers
Karis Findlan Kraemer Karis Findlan Kraemer
Director, Supply Chain and Project Management
Vetter Development Service USA Inc.

 

Karis joined Vetter Development Services USA in 2012 as a Project Manager and since 2014 has led the Supply Chain and Project Management teams at Vetter’s first US site in Chicago, focused on early clinical phase drug product manufacturing for Vetter’s global customers. Before joining Vetter, Karis spent several years at Hospira (now part of Pfizer) in Program Management and Regulatory Affairs roles, worked at Abbott Laboratories in Process Validation and as a Validation Consultant at KMI/Parexel. Karis received her bachelor’s degree in biology from Clearwater Christian College in Florida.

Chervee Ho Chervee Ho
Director of Key Account Management, Asia Pacific
Vetter Pharma International GmbH Singapur

 

Chervee leads Vetter’s Asia Pacific business development team, as well as our regional office in Singapore and rapidly growing sales offices in Japan and South Korea. She has been active in the pharmaceutical and diagnostics industries since 1994, and has extensive experience in both commercial pharmaceutical manufacturing and in-vitro diagnostic (IVD) products. At Vetter, her primary focus is on expanding our engagement with pharmaceutical and biotech companies across the Asia Pacific market, as well as developing local team structures to support our diverse and expanding base of customers in multiple countries across the region. She holds a Bachelor’s Degree (HONS) in Biotechnology with a major in Genetic Engineering from the University of Putra Malaysia.



報名參加